Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1) is a protein found mainly in neuronal and endothelial cells and is involved in regulating signal transduction pathways including the p53 and MAPK pathways. KNDC1 serves as a scaffold or protein-protein interaction module rather than a catalytic kinase; it is implicated in processes such as cellular senescence, cell proliferation, dendritic development in neurons, and angiogenesis. Knockdown of KNDC1 in endothelial cells promotes proliferation, delays senescence, and enhances tube formation by affecting the p53-p21-p16 pathway and ERK signaling, while overexpression accelerates senescence via a p53–reactive oxygen species positive feedback loop[1][2]. KNDC1 is considered a candidate therapeutic target for modulating cellular aging and possibly for treating age-related vascular or neuronal diseases. No direct pharmacological agents or biomarkers specific to KNDC1 are currently established in the literature.
Modulation of p53 signaling pathway (senescence induction), Regulation of MAPK (ERK) pathway for cell proliferation, p53–ROS positive feedback loop activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1).